Easy‐Amanida: An R Shiny application for the meta‐analysis of aggregate results in clinical metabolomics using Amanida and Webchem

M Llambrich, P Satorra, E Correig… - Research Synthesis …, 2024 - Wiley Online Library
Meta‐analysis is a useful tool in clinical research, as it combines the results of multiple
clinical studies to improve precision when answering a particular scientific question. While …

[HTML][HTML] Indoleamine 2, 3-dioxygenase (IDO1)–Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson's Disease?

M Gonçalves, P Rodrigues-Santos, C Januário… - International …, 2024 - Elsevier
Parkinson's Disease (PD) is the second most common neurodegenerative disease where
central and peripheral immune dysfunctions have been pointed out as a critical component …

Untargeted serum metabolic profiling of diabetes mellitus among Parkinson's disease patients

S Li, Y Lin, D Jones, DI Walker, A Duarte Folle… - npj Parkinson's …, 2024 - nature.com
Type 2 diabetes mellitus (T2DM) is a common comorbidity among Parkinson's disease (PD)
patients. Yet, little is known about dysregulated pathways that are unique in PD patients with …

Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain

M Scholefield, SJ Church, J Xu… - Journal of …, 2024 - content.iospress.com
Background: Localized pantothenic acid deficiencies have been observed in several
neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease …

Untargeted Plasma Metabolomics Unveils Distinct Metabolite Profiles in Parkinson Disease Subtypes: A Focus on idiopathic REM Sleep Behavior Disorders

S Lee, J Kim, J Baek, KY Jung, Y Lee, A Koh, HJ Kim - bioRxiv, 2024 - biorxiv.org
Background: Parkinson's disease (PD) is characterized by diverse clinical presentations and
etiological complexities, with rapid eye movement (REM) sleep behavior disorder (RBD) …